Systemic treatments (EADV 2026) - Jun 29, 2026 - Abstract #D2T05.2D; Pres time: Oct 1, 2026; 11:15 AM - 11:35 AM; Location: Hall F1; "Alitretinoin remains the systemic benchmark in chronic hand eczema, while dupilumab and emerging targeted therapies are redefining expectations for selected patient groups. 4. Understand how emerging immunological and molecular insights are shaping the next generation of targeted treatment strategies."
Contact Dermatitis • Dermatology • Immunology • SYK
|